Revenue: As of FY2025, the actual value is USD 124.16 K.<h4>Financial Performance for the Year Ended December 31, 2025 (vs. 2024)</h4><h4>Revenue and Gross Profit</h4><ul><li>Total Revenue: Ainos, Inc. reported $124,157 in revenue for 2025, an increase from $20,729 in 2024, reflecting approximately 499% year-over-year growth, mainly driven by AI Nose commercialization .</li><li>Cost of Revenues: The cost of revenues was - $21,246 in 2025, compared to - $52,595 in 2024 .</li><li>Gross Profit (Loss): The company achieved a gross profit of $102,911 in 2025, a substantial improvement from a gross loss of - $31,866 in 2024 .</li><li>Gross Margin: Gross margin turned positive to approximately 82.9% in 2025, compared to a gross loss in 2024 .</li></ul><h4>Operating Expenses and Loss</h4><ul><li>Research and Development Expenses: These decreased to $7,749,772 in 2025 from $8,413,923 in 2024 .</li><li>Selling, General and Administrative Expenses: These increased to $6,343,547 in 2025 from $5,395,415 in 2024 .</li><li>Total Operating Expenses: Total operating expenses were $14,093,319 in 2025, up from $13,809,338 in 2024 . Excluding share-based compensation, depreciation, and amortization, total operating expenses decreased 9% year-over-year, while reported operating expense increased about 2% .</li><li>Loss from Operations: The loss from operations was - $13,990,408 in 2025, compared to - $13,841,204 in 2024 .</li></ul><h4>Non-Operating Items and Net Loss</h4><ul><li>Interest Expense: Interest expense was - $711,903 in 2025, up from - $616,467 in 2024 .</li><li>Other Non-Operating Expenses, Net: Total non-operating expenses, net, were - $779,804 in 2025, an improvement from - $1,021,157 in 2024 .</li><li>Net Loss: Ainos, Inc. reported a net loss of - $14,771,012 for 2025, slightly less than the net loss of - $14,863,161 in 2024 .</li></ul><h4>Balance Sheet Highlights (as of December 31, 2025 vs. 2024)</h4><ul><li>Cash and Cash Equivalents: Decreased to $417,353 in 2025 from $3,892,919 in 2024 .</li><li>Total Assets: Total assets were $20,871,108 in 2025, down from $28,820,199 in 2024 .</li><li>Total Liabilities: Total liabilities slightly increased to $13,308,526 in 2025 from $13,303,889 in 2024 .</li><li>Total Stockholders’ Equity: Total stockholders’ equity decreased to $7,562,582 in 2025 from $15,516,310 in 2024 .</li><li>Accumulated Deficit: The accumulated deficit grew to - $67,520,328 in 2025 from - $52,749,316 in 2024 .</li><li>Contract Liabilities: Increased to $350,000 in 2025 from $106,329 in 2024 .</li><li>Convertible Notes Payable (Non-current): Increased to $11,000,000 in 2025 from $9,000,000 in 2024 .</li></ul><h4>Outlook / Guidance for 2026</h4>Ainos, Inc. is entering 2026 with operational momentum, particularly with early AI Nose deployments underway in semiconductor environments . Approximately 200 AI Nose systems were launched for technical validation in Q1 2026, and around 1,400 systems are targeted for completion in Q2 2026 under a three-year $2.1 million deployment in semiconductor packaging and testing environments . These deployments are expected to support system integration and real-world data generation, forming a foundation for scaled commercial rollout and revenue activation .

Ainos | 8-K: FY2025 Revenue: USD 124.16 K